Stelara 130 mg/26 mL injection Images
Generic Name: ustekinumab
This medication has been identified as Stelara 130 mg/26 mL injection. It is supplied by Janssen Biotech, Inc.
Stelara is used in the treatment of Crohn's Disease, Active; Crohn's Disease; Psoriasis; Plaque Psoriasis; Psoriatic Arthritis and belongs to the drug class interleukin inhibitors. There is no proven risk in humans during pregnancy. Stelara 130 mg/26 mL injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Stelara
- Generic Name
- ustekinumab
- Strength
- 130 mg/26 mL injection
- Availability
- Prescription only
- Drug Class
- Interleukin inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Janssen Biotech, Inc.
- National Drug Code (NDC)
- 57894-0054
More about Stelara (ustekinumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (240)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: interleukin inhibitors
- Breastfeeding
Patient resources
- Stelara drug information
- Stelara (Ustekinumab Intravenous Infusion)
- Stelara (Ustekinumab Subcutaneous Injection)
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
